Literature DB >> 6273631

Further studies on the synthesis of A-form monoamine oxidase.

T Egashira, Y Yamanaka.   

Abstract

The relation between precursors and restoration of A-form MAO activity in rat liver after administration of clorgyline to rats was investigated by measuring the rates of recovery of A-form MAO activity after treatment with the inhibitor. The half-lives of mitochondrial and microsomal A-form MAO were estimated as 3.5 and 2.0 days, respectively. MAO activity and the amount of MAO molecules were completely restored within 14 days. However the values attained did not exceed the control values in a period of 14 days. Clorgyline plus cycloheximide or chloramphenicol did not prevent the recovery of MAO activity in the microsomes, but did not delay the appearance of enzyme activity in the mitochondria. A and B-form-like MAO were also observed in the microsomal and supernatant fractions, with clorgyline as inhibitor. These results suggest that the microsomal enzyme is a precursor of the mitochondrial enzyme, that the levels of A-form and B-form MAO are regulated genetically, and that the two forms of MAO may be synthesized separately.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273631     DOI: 10.1254/jjp.31.763

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Structure and promoter organization of the human monoamine oxidase A and B genes.

Authors:  J C Shih; J Grimsby; K Chen; Q S Zhu
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

Review 2.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

Review 3.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.